Trump administration will allow pharmacies to make popular peptides
AI Summary
The Trump administration has decided to permit small compounding pharmacies to produce six popular peptides, which haven't yet been approved by the FDA, potentially addressing shortages and meeting demand. This move could reshape the landscape of peptide-based treatments, although it remains to be seen if it will fully alleviate supply issues. This decision reflects a shift in regulatory enforcement, allowing for more flexible, localized production in response to specific medical needs.
Original Source
Read the full article at Npr →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.